Fatima Galan-Sanchez
Overview
Explore the profile of Fatima Galan-Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Virues-Segovia J, Pinedo-Rivilla C, Munoz-Mira S, Ansino M, Gonzalez-Rodriguez V, Ezzanad A, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940680
Thiochroman derivatives are highly versatile molecules widely used for the synthesis of novel heterocycles and bioactive compounds. In our study, we conducted the biotransformation of thiochroman-4-ol () and 6-chlorothiochroman-4-ol ()...
2.
Rodriguez-Pallares S, Mateo-Vargas M, Rodriguez-Iglesias M, Arca-Suarez J, Galan-Sanchez F
Eur J Clin Microbiol Infect Dis
. 2025 Jan;
PMID: 39838141
Purpose: To prospectively monitor the evolution of the resistome of OXA-48-producing Klebsiella species in a patient with long-term colonization, with a particular focus into the plasmid dynamics and the evolution...
3.
Candel F, Salavert M, Canton R, Del Pozo J, Galan-Sanchez F, Navarro D, et al.
Crit Care
. 2024 Dec;
28(1):440.
PMID: 39736683
Rapid multiplex molecular syndromic panels (RMMSP) (3 or more pathogens and time-to-results < 6 h) allow simultaneous detection of multiple pathogens and genotypic resistance markers. Their implementation has revolutionized the...
4.
Rodriguez-Pallares S, Blanco-Martin T, Lence E, Aja-Macaya P, Sanchez-Pena L, Gonzalez-Pinto L, et al.
Antimicrob Agents Chemother
. 2024 Nov;
68(12):e0130724.
PMID: 39503481
We describe the emergence of resistance to ceftazidime/avibactam via modification of AmpC in a clinical isolate during therapy with this combination. Paired ceftazidime/avibactam-susceptible/resistant isolates were obtained before and during ceftazidime/avibactam...
5.
Fernandez-Palacios P, Galan-Sanchez F, Casimiro-Soriguer C, Jurado-Tarifa E, Arroyo F, Lara M, et al.
Microbiol Spectr
. 2024 Aug;
12(10):e0102824.
PMID: 39162511
is the main cause of bacterial gastroenteritis and a public health problem worldwide. Little information is available on the genotypic characteristics of human in Spain. This study is based on...
6.
Gomez-Romano M, Rodriguez-Iglesias M, Galan-Sanchez F
Microorganisms
. 2024 May;
12(5).
PMID: 38792745
spp. and Microsporidia are opportunistic microorganisms with remarkable zoonotic transmission potential due to their capacity to infect humans and animals. The aim of this study was to evaluate the prevalence...
7.
Guedes M, Gathara D, Lopez-Hernandez I, Martinez Perez-Crespo P, Perez-Rodriguez M, Sousa A, et al.
Ann Clin Microbiol Antimicrob
. 2024 May;
23(1):42.
PMID: 38711045
Background: Klebsiella aerogenes has been reclassified from Enterobacter to Klebsiella genus due to its phenotypic and genotypic similarities with Klebsiella pneumoniae. It is unclear if clinical outcomes are also more...
8.
Maldonado N, Lopez-Hernandez I, Lopez-Cortes L, Martinez Perez-Crespo P, Retamar-Gentil P, Garcia-Montaner A, et al.
Clin Microbiol Infect
. 2024 Apr;
30(8):1035-1041.
PMID: 38599464
Objectives: This study aimed to determine the association of Escherichia coli microbiological factors with 30-day mortality in patients with bloodstream infection (BSI) presenting with a dysregulated response to infection (i.e....
9.
Maldonado N, Lopez-Hernandez I, Garcia-Montaner A, Lopez-Cortes L, Martinez Perez-Crespo P, Retamar-Gentil P, et al.
Lancet Microbe
. 2024 Mar;
5(4):e390-e399.
PMID: 38547882
Background: Escherichia coli is the most frequent cause of bloodstream infections (BSIs). About one-third of patients with BSIs due to E coli develop sepsis or shock. The objective of this...
10.
Giron-Ortega J, Fernandez-Guerrero R, de Oca Arjona M, Galan-Sanchez F, Sagastizabal G, Romea E, et al.
J Infect
. 2023 Nov;
88(2):95-102.
PMID: 38036182
Objectives: To evaluate the appropriateness of antimicrobial treatment and the risk factors for mortality in patients with negative blood cultures (BC), in order to evaluate whether this population would be...